Literature DB >> 15681463

Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase.

Shane C McAllister1, Scott G Hansen, Ilhem Messaoudi, Janko Nikolich-Zugich, Ashlee V Moses.   

Abstract

Expression of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic genes is thought to be essential for the establishment and progression of KSHV-induced diseases. The inefficiency of lytic reactivation in various in vitro systems hampers the study of lytic genes in the context of whole virus. We report here increased expression of KSHV lytic genes and increased release of progeny virus when synchronized cultures of body cavity-based lymphoma-1 cells are treated with a phorbol ester during S phase of the cell cycle.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15681463      PMCID： PMC546546          DOI： 10.1128/JVI.79.4.2626-2630.2005

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  20 in total

1.  Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines.

Authors:  J Paul Zoeteweij; Andrea S Rinderknecht; David A Davis; Robert Yarchoan; Andrew Blauvelt
Journal:  J Med Virol       Date:  2002-03       Impact factor: 2.327

2.  Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Authors:  Ayumi Kudoh; Tohru Daikoku; Yutaka Sugaya; Hiroki Isomura; Masatoshi Fujita; Tohru Kiyono; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8.

Authors:  C Blasig; C Zietz; B Haar; F Neipel; S Esser; N H Brockmeyer; E Tschachler; S Colombini; B Ensoli; M Stürzl
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication.

Authors:  J Chang; R Renne; D Dittmer; D Ganem
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

6.  Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus.

Authors:  D A Davis; A S Rinderknecht; J P Zoeteweij; Y Aoki; E L Read-Connole; G Tosato; A Blauvelt; R Yarchoan
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Jeffrey Vieira; Patricia M O'Hearn
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

8.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

9.  Polyomavirus large and small T antigens cooperate in induction of the S phase in serum-starved 3T3 mouse fibroblasts.

Authors:  E Ogris; I Mudrak; E Wintersberger
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.

Authors:  Ayumi Kudoh; Masatoshi Fujita; Tohru Kiyono; Kiyotaka Kuzushima; Yutaka Sugaya; Shunji Izuta; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103
View more
  13 in total

1.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins.

Authors:  Ossie F Dyson; Telisha L Oxendine; Khalief E Hamden; Patrick W Ford; Shaw M Akula
Journal:  Cell Microbiol       Date:  2008-03-25       Impact factor: 3.715

3.  Functional Imaging of Viral Transcription Factories Using 3D Fluorescence Microscopy.

Authors:  Christopher P Chen; Frank Chuang; Yoshihiro Izumiya
Journal:  J Vis Exp       Date:  2018-01-18       Impact factor: 1.355

4.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

5.  Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.

Authors:  Yi Zeng; Xunhai Zhang; Zan Huang; Lin Cheng; Shuihong Yao; Di Qin; Xiuying Chen; Qiao Tang; Zhigang Lv; Ling Zhang; Chun Lu
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

6.  Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.

Authors:  Arunava Roy; Dipanjan Dutta; Jawed Iqbal; Gina Pisano; Olsi Gjyshi; Mairaj Ahmed Ansari; Binod Kumar; Bala Chandran
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

7.  Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Santarelli; A Farina; M Granato; R Gonnella; S Raffa; L Leone; R Bei; A Modesti; L Frati; M R Torrisi; A Faggioni
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

8.  miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA.

Authors:  Xianzhi Lin; Deguang Liang; Zhiheng He; Qiang Deng; Erle S Robertson; Ke Lan
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

9.  A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression.

Authors:  Sumit Borah; Nicole Darricarrère; Alicia Darnell; Jinjong Myoung; Joan A Steitz
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

10.  Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.

Authors:  Di Qin; Ninghan Feng; Weifei Fan; Xinting Ma; Qin Yan; Zhigang Lv; Yi Zeng; Jianzhong Zhu; Chun Lu
Journal:  BMC Microbiol       Date:  2011-10-27       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.